These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2502460)

  • 1. Aldose reductase inhibition and glomerular abnormalities in diabetic rats.
    Daniels BS; Hostetter TH
    Diabetes; 1989 Aug; 38(8):981-6. PubMed ID: 2502460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glomerular basement membrane thickening in streptozotocin diabetic rats despite treatment with an aldose reductase inhibitor.
    Osterby R; Gundersen HJ
    J Diabet Complications; 1989; 3(3):149-53. PubMed ID: 2528558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of hemodynamic and vascular albumin filtration changes in diabetic rats by aldose reductase inhibitors.
    Tilton RG; Chang K; Pugliese G; Eades DM; Province MA; Sherman WR; Kilo C; Williamson JR
    Diabetes; 1989 Oct; 38(10):1258-70. PubMed ID: 2507378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of aldose reductase inhibitors on glomerular prostaglandin production and urinary albumin excretion in experimental diabetes mellitus.
    Chang WP; Dimitriadis E; Allen T; Dunlop ME; Cooper M; Larkins RG
    Diabetologia; 1991 Apr; 34(4):225-31. PubMed ID: 1906023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on peripheral nerve and lens in long-term experimental diabetes: effects of the aldose reductase inhibitor statil.
    Willars GB; Townsend J; Tomlinson DR; Compton AM; Churchill RD
    Metabolism; 1988 May; 37(5):442-9. PubMed ID: 2452959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscarinic receptor density is reduced in diabetic rat atria, an effect prevented by the aldose reductase inhibitor, Statil.
    Kofo-Abayomi A; Lucas PD
    J Pharm Pharmacol; 1987 Dec; 39(12):1019-21. PubMed ID: 2894428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axonal transport and tissue contents of substance P in rats with long-term streptozotocin-diabetes. Effects of the aldose reductase inhibitor 'statil'.
    Robinson JP; Willars GB; Tomlinson DR; Keen P
    Brain Res; 1987 Nov; 426(2):339-48. PubMed ID: 2446712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldose reductase inhibition by ponalrestat (statil) does not prevent proteinuria in long-term diabetic rats.
    Reddi AS; Jyothirmayi GN
    J Diabetes Complications; 1993; 7(4):233-40. PubMed ID: 8219366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldose reductase inhibition, glomerular metabolism, and diabetic nephropathy.
    Cohen M
    Diabet Med; 1985 May; 2(3):203-6. PubMed ID: 3032499
    [No Abstract]   [Full Text] [Related]  

  • 10. Sorbinil prevents glomerular hyperperfusion in diabetic rats.
    Bank N; Mower P; Aynedjian HS; Wilkes BM; Silverman S
    Am J Physiol; 1989 Jun; 256(6 Pt 2):F1000-6. PubMed ID: 2500028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Slow component-a of axonal transport, nerve myo-inositol, and aldose reductase inhibition in streptozocin-diabetic rats.
    Tomlinson DR; Sidenius P; Larsen JR
    Diabetes; 1986 Apr; 35(4):398-402. PubMed ID: 2420664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sorbinil suppresses glomerular prostaglandin production in the streptozotocin diabetic rat.
    Craven PA; DeRubertis FR
    Metabolism; 1989 Jul; 38(7):649-54. PubMed ID: 2500578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced anterograde and retrograde accumulation of axonally transported phosphofructokinase in streptozotocin-diabetic rats: effects of insulin and the aldose reductase inhibitor 'Statil'.
    Willars GB; Calcutt NA; Tomlinson DR
    Diabetologia; 1987 Apr; 30(4):239-43. PubMed ID: 2439402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of aldose reductase inhibition on nerve conduction velocity and resistance to ischemic conduction block in experimental diabetes.
    Price DE; Airey CM; Alani SM; Wales JK
    Diabetes; 1988 Jul; 37(7):969-73. PubMed ID: 3133261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of aldose reductase inhibitor ONO 2235 on reduced sympathetic nervous system activity and peripheral nerve disorders in STZ-induced diabetic rats.
    Yoshida T; Nishioka H; Yoshioka K; Nakano K; Kondo M; Terashima H
    Diabetes; 1987 Jan; 36(1):6-13. PubMed ID: 3025043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with an aldose reductase inhibitor can reduce the susceptibility of fast axonal transport following nerve compression in the streptozotocin-diabetic rat.
    Dahlin LB; Archer DR; McLean WG
    Diabetologia; 1987 Jun; 30(6):414-8. PubMed ID: 2445613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amelioration of glomerular hyperfiltration in acute experimental diabetes mellitus by dietary myo-inositol supplementation and aldose reductase inhibition.
    Goldfarb S; Simmons DA; Kern EF
    Trans Assoc Am Physicians; 1986; 99():67-72. PubMed ID: 3111062
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of statil on kidney structure, function and polyol accumulation in diabetes mellitus.
    Faiman G; Ganguly P; Mehta A; Thliveris JA
    Mol Cell Biochem; 1993 Aug; 125(1):27-33. PubMed ID: 8264569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of aldose reductase inhibitor, statil, on hyperpermeability of iridial vessels in experimental galactosemic rats.
    Terubayashi H; Akagi Y
    Jpn J Ophthalmol; 1989; 33(3):343-7. PubMed ID: 2507812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Permeability changes at blood-retinal barrier in diabetes and effect of aldose reductase inhibition.
    Lightman S; Pinter G; Yuen L; Bradbury M
    Am J Physiol; 1990 Sep; 259(3 Pt 2):R601-5. PubMed ID: 2118733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.